Streetbeat News

TIVC

Tivic Health Systems, Inc.

https://www.tivichealth.com

Industry

Medical - Devices

Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. Its primary product is ClearUP, is a medical device intended to relieve sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, including BestBuy.com and FSAStore.com. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

Duolingo shares fell by 18% after reporting Q1 financial results, despite beating analyst estimates for earnings and sales. The company's Q2 and full-year revenue forecasts were slightly below estimates. Other stocks showed significant movement, with notable gainers including Pop Culture Group, Sezzle Inc., and Safe and Green Development, among others. Losers included Tivic Health Systems, EMCORE Corporation, and CytomX Therapeutics, with various reasons such as public offerings, mixed financial results, and clinical study data.

Portfolio Pulse from Avi Kapoor

May 09, 2024 | 5:57 pm

Healthcare stocks experienced significant movements in Thursday's intraday session, with notable gainers including Embecta, Seres Therapeutics, G1 Therapeutics, Vaccinex, Zai Lab, and CareCloud, primarily driven by recent earnings reports. Conversely, Tivic Health Systems, CytomX Therapeutics, RAPT Therapeutics, Syra Health, NeuroPace, and Reviva Pharmaceuticals saw sharp declines, also influenced by their earnings outcomes.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 4:31 pm

Tivic Health Systems Inc (NASDAQ:TIVC) shares plummeted by 61% to $0.52 after announcing the pricing of its public offering at $0.85 per share, including Series A and Series B warrants. The offering aims to raise approximately $4 million, with Maxim Group LLC as the sole placement agent. The significant drop in share price reflects investor concerns over the dilution of existing shares and the low offering price compared to the stock's 52-week high of $23.79.

Portfolio Pulse from Henry Khederian

May 09, 2024 | 4:01 pm

U.S. stocks saw an uptick with the Dow Jones rising over 150 points, attributed partly to US Foods Holding Corp's upbeat earnings report. US Foods exceeded first-quarter FY24 sales and EPS estimates, contributing to positive market sentiment. Additionally, Pop Culture Group, Sezzle Inc., and Consensus Cloud Solutions experienced significant share price increases following their positive financial results. Conversely, Tivic Health Systems, EMCORE Corporation, and CytomX Therapeutics saw substantial declines in their share prices due to less favorable financial outcomes or updates.

Portfolio Pulse from Avi Kapoor

May 09, 2024 | 4:01 pm

U.S. stocks showed mixed performance with the Dow Jones slightly down and NASDAQ up. Jobless claims rose unexpectedly, affecting market sentiment. Pop Culture Group, Sezzle Inc., and Embecta Corp. saw significant stock price increases following positive financial reports, while Tivic Health Systems, EMCORE Corporation, and Cardlytics faced declines after disappointing financial updates or guidance. The real estate sector led gains, while financial shares dropped.

Portfolio Pulse from Avi Kapoor

May 09, 2024 | 1:47 pm

Tivic Health Systems Inc. has announced the pricing of a $4 million public offering, aiming to raise funds for general corporate purposes, including working capital. This move could indicate the company's need for financial strengthening or expansion efforts.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 1:27 pm

AppLovin Corporation shares surged 15% in pre-market trading after reporting Q1 financial results that exceeded expectations, with revenue of $1.058 billion and earnings of 67 cents per share. Other stocks also showed significant movement in pre-market trading, with notable gainers including Pop Culture Group, Sezzle Inc., and Compass, Inc., among others. On the losing end, Tivic Health Systems, CytomX Therapeutics, and Cardlytics, Inc. saw substantial declines after their respective announcements.

Portfolio Pulse from Avi Kapoor

May 09, 2024 | 12:13 pm

Health care stocks showed significant movement in Thursday's pre-market session, with Zai Lab, ZimVie, Aadi Bioscience, CEL-SCI, Tarsus Pharmaceuticals, and Embecta posting gains following their earnings reports. Conversely, Tivic Health Systems, CytomX Therapeutics, CNS Pharma, Ironwood Pharmaceuticals, Syra Health, and Exact Sciences experienced declines, also influenced by their earnings releases.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 12:06 pm

Upstart Holdings, Inc. (UPST) shares fell by 10.3% after reporting Q1 financial results and issuing Q2 revenue guidance below estimates. Other stocks showed significant movement, with Reborn Coffee, Inc. (REBN) leading gainers with a 132.9% jump after announcing a market expansion into China. On the losing end, Treace Medical Concepts, Inc. (TMCI) dropped 60.8% after issuing FY24 revenue guidance below estimates.

Portfolio Pulse from Avi Kapoor

May 08, 2024 | 5:38 pm

Tivic Health Systems, Inc. (NASDAQ:TIVC) shares surged after announcing positive results from its pilot study on non-invasive cervical vagus nerve stimulation (ncVNS), showing effectiveness in major disease areas. The study's success and heavy trading volume, with over 20.6 million shares traded compared to a 100-day average of less than 112,000, highlight investor interest. Tivic Health does not pay dividends but engages in other value-returning activities.

Portfolio Pulse from Erica Kollmann

May 08, 2024 | 4:53 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.